GLG Topic: Diabetes
Diabetes is a disease characterized by the body's inability to sufficiently produce insulin to properly metabolize carbohydrates. The three main forms the condition are Type 1, Type 2, and gestational diabetes. Type 1 diabetes is a chronic disease characterized by destruction of beta-cells of the pancreas. Type 2 diabetes develops when the body becomes resistant to the effects of insulin. Gestational diabetes is usually a temporary disorder occurring during pregnancy when insulin resistance develops due to hormonal changes and weight gain.
Request a consultation
Leading Experts: Diabetes
![]() |
What is a GLG Leader? |
Michael DempseyMedical Director
Johns Hopkins Diabetes Center at Suburban Hospital
Michael Dempsey, MD, is a Private Practitioner in Rockville, Maryland. He is the Medical Director of the Johns Hopkins Diabetes Center at Suburban Hospital, where he is also the Medical Director of Diabetes Education and Endocrine Subsection Chair. He is the Vice-President of the Mid-Atlantic chapter...
Associate Professor and Director
THE GEORGE WASHINGTON UNIVERSITY
Joshua Cohen, MD, is an Associate Professor of Medicine and Director of the Diabetes Center in the Division of Endocrinology and Metabolism at The George Washington University Medical Center. He was a Medical Staff Fellow at the National Institutes of Arthritis, Diabetes, Digestive and Kidney Diseases,...
Clinical Professor of Medicine
University of California, Los Angeles
Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is the Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja...
Chief of Young Adult Diabetes Clinic
BARBARA DAVIS CENTER FOR CHILDHOOD DIABETES
Satish Garg, MD, is a Professor of Medicine and Pediatrics at University of Colorado School of Medicine. He is also Chief of Young Adult Diabetes Clinic and Director of Barbara Davis Center for Childhood Diabetes at University of Colorado Health Sciences Center. Dr. Garg has research interest in microvascular...
Director, Diabetes Outpatient Department
SUNY Downstate Medical Center - CC
RoseMarie Pasmantier, MD, is the Director of Diabetes Outpatient Department at State University of New York at Stony Brook. Dr. Pasmantier has experience in the treatment of metabolic disorders. Her research interests include new treatments for type 2 diabetes and dyslipidemia. Dr. Pasmantier has been...
Study Groups: Diabetes(?)
GLG NewsSM
Analysis: Diabetes(?)
The most obvious (potential) benefit to Lilly of its collaboration agreement with Transition is that it will be adding one more potential class of diabetic therapies to its product line. Lilly already has Humulin (longer-acting insulin), Humalog (a rapid acting insulin), Actos and exenatide (a...
India will become capital of diabetes in few years This molecule will help diabetic patients with neuropathic pain. aT PRESENT PREGABALIN GABAPENTIN and Methylcobalamin IS USED TO TREAT NEUROPATHY with variable results.
Diabetes is one of most common disease suffered by millions around the world, yet treatment options are limited, and mainly confined with few oral medicines, insulin regulator bio-chemical treatment and other alternative medicines. The prospect of AEG33773, as an orally bioavailable small molecule...
The market is hungry for a weight loss drug with diabetes benefit. Currently, the FAD has phobia of the SEs with new drugs in this category Failure of Rimonabant was due to wrong direction of Sanofi Aventis in their approach to the FDA Taranabant may have better luck, especially if Merck take...
Situins are enzymes that regulate predetermined cell death, activity in muscle and fat cells as well as energy expenditure. There are several classes of these enzymes (SIRT 1 through 7). The technology is promising in that it promises to regulate some of the causes of diabetes and obesity rather than...
GLG InstituteSM
Seminars: Diabetes(?)
Recent Seminars
Quick Facts about GLG
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms


